Enlivex Therapeutics Statistics
Total Valuation
ENLV has a market cap or net worth of $27.59 million. The enterprise value is $4.16 million.
| Market Cap | 27.59M |
| Enterprise Value | 4.16M |
Important Dates
The next estimated earnings date is Friday, August 30, 2024, after market close.
| Earnings Date | Aug 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ENLV has 20.87 million shares outstanding.
| Shares Outstanding | 20.87M |
| Owned by Insiders (%) | 5.95% |
| Owned by Institutions (%) | 8.73% |
| Float | 16.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.86, with zero debt.
| Current Ratio | 7.86 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 77.89 |
Financial Efficiency
Return on equity (ROE) is -74.20% and return on invested capital (ROIC) is -99.67%.
| Return on Equity (ROE) | -74.20% |
| Return on Assets (ROA) | -61.90% |
| Return on Capital (ROIC) | -99.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$366,056 |
| Employee Count | 71 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.06% in the last 52 weeks. The beta is 1.25, so ENLV's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -49.06% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 2.19 |
| Relative Strength Index (RSI) | 43.10 |
| Average Volume (20 Days) | 91,375 |
Short Selling Information
| Short Interest | 140,810 |
| Short Previous Month | 157,338 |
| Short % of Shares Out | 0.72% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.76M |
| Pretax Income | -25.99M |
| Net Income | -25.99M |
| EBITDA | -25.51M |
| EBIT | -26.33M |
| Earnings Per Share (EPS) | -$1.39 |
Balance Sheet
The company has $23.44 million in cash and no debt, giving a net cash position of $23.44 million or $1.12 per share.
| Cash & Cash Equivalents | 23.44M |
| Total Debt | n/a |
| Net Cash | 23.44M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 26.85M |
| Book Value Per Share | 1.29 |
| Working Capital | 24.77M |
Cash Flow
In the last 12 months, operating cash flow was -$22.25 million and capital expenditures $240,000, giving a free cash flow of -$22.01 million.
| Operating Cash Flow | -22.25M |
| Capital Expenditures | 240,000 |
| Free Cash Flow | -22.01M |
| FCF Per Share | -$1.18 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENLV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.14% |
| Shareholder Yield | -1.14% |
| Earnings Yield | -94.19% |
| FCF Yield | -79.76% |
Analyst Forecast
The average price target for ENLV is $6.00, which is 353.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 353.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 6, 2019. It was a reverse split with a ratio of 1:8.
| Last Split Date | Mar 6, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |